Aspen Pharmacare (OTCMKTS:APNHY) Sets New 52-Week Low - Here's What Happened

Key Points

• Aspen Pharmacare reached a new 52-week low, trading at $5.40 and closing at $5.45, down from a previous close of $5.84.
• The company's current ratio is 2.21, indicating a solid liquidity position, while it has a debt-to-equity ratio of 0.37, suggesting manageable debt levels.
• Aspen Pharmacare operates in the pharmaceutical sector, specializing in products like general anesthetics and injectable anticoagulants.

Aspen Pharmacare (OTCMKTS:APNHY - )'s share price hit a new 52-week low on Thursday . The company traded as low as $5.40 and last traded at $5.45, with a volume of 640 shares. The stock had previously closed at $5.84.

Aspen Pharmacare Price Performance

The business's 50-day moving average is $6.18 and its two-hundred day moving average is $7.00. The company has a current ratio of 2.21, a quick ratio of 1.18 and a debt-to-equity ratio of 0.37.

About Aspen Pharmacare

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.